US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 10.7000
  • -0.3900-3.52%
Trading Nov 12 15:05 ET
721.48MMarket Cap-6445P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Perspective Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
153.23K
-91.97%
EPS
-0.21
+46.29%
Analyst Rating
Strong Buy

Nov 12, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 157.810K --
Nov 12, 2024 2024/Q3 -- / 153.230K --
Aug 12, 2024 2024/Q2 526.000K / 135.630K --
May 15, 2024 2024/Q1 325.000K / 68.800K --
-- 2023/Q4 -4.902M / 2.122M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 157.810K--
Nov 12, 20242024/Q3-- / 153.230K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
--2023/Q4-4.902M / 2.122M--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

  • Perspective Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:10

  • Perspective Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 16 10:44

  • Perspective Therapeutics | 10-K: FY2023 Annual Report

    Mar 28 20:39

  • Perspective Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 15, 2023 05:59

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data